Marcella Bothwell, MD, MBA

Non profit Founder and leader greater San Diego Area

📍 United States🔄 Updated September 2026💼 4 investments📅 11 years investing🗓 Last invested Jan 2017
Operator-angel🌍 United States
4
Total investments
2
Early stage
0
Mid stage
0
Late stage
11y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2017
make-break-innovate Chronus Healths portable platform is designed to allow real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Please visit our website for additional information.
Investor
2016
Fruit Street delivers the CDCs Diabetes Prevention Program using telehealth, wearable devices, and mobile applications. The diabetes prevention program is a 1-year long diet and lifestyle intervention designed to help pre-diabetic patients lose 5-7% of their weight through diet and lifestyle changes. The program is based on clinical research that was published in the New England Journal of Medicine in 2002 which showed that patients who complete the program have a 58% risk reduction for developing diabetes.
Investor
2015
CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems. CB Therapeutics’ expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms. CB Therapeutics is focused on the discovery, research, development and production of tryptamines, cannabinoids and other molecules and compounds to advance Neuroscience and bring therapeutics to market to solve mankind’s most challenging mental healthcare and social problems.
early stageBiotechnology
Experience · 5 entries
All (5)
Investments (4)
Founder (1)
Board (1)
2018
Treasurer, Founder, Past Marketing Chair
Nov 2018
The San Diego Parks Foundation strives to connect all San Diegans to high-quality parks through philanthropic and volunteer contributions to the City of San Diego Parks and Recreation Department, and to support the City’s mission to build a world-class inclusive park system that strengthens communities and provides equitable access to recreational opportunities.
2017
City of San Diego Parks and Recreation Board Member
2017
The City of San Diego is dedicated to helping foster the regions economic base to improve the quality of life for its citizens and business community. CITY HALL: City Council meets on Mondays at 2 p.m. and on Tuesdays at 10 a.m. at the City Administration Building, 12th floor, 202 C St. in downtown San Diego. View the City Council Docket and City Council Meeting Webcast Archives online: bit.ly/2o6hUTm. FOLLOW US: Facebook.com/CityofSanDiego X.com/CityofSanDiego/ Instagram: @thecityofsandiego Threads:@cityofsandiego YouTube: https://goo.gl/7ouxaq
Investor
2017
make-break-innovate Chronus Healths portable platform is designed to allow real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Please visit our website for additional information.
2016
Investor
2016
Fruit Street delivers the CDCs Diabetes Prevention Program using telehealth, wearable devices, and mobile applications. The diabetes prevention program is a 1-year long diet and lifestyle intervention designed to help pre-diabetic patients lose 5-7% of their weight through diet and lifestyle changes. The program is based on clinical research that was published in the New England Journal of Medicine in 2002 which showed that patients who complete the program have a 58% risk reduction for developing diabetes.
2015
Investor
2015
CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems. CB Therapeutics’ expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms. CB Therapeutics is focused on the discovery, research, development and production of tryptamines, cannabinoids and other molecules and compounds to advance Neuroscience and bring therapeutics to market to solve mankind’s most challenging mental healthcare and social problems.
early stageBiotechnology
Investment activity
2015–2017 · 4 investments
201512016120172
Recent (last 2 years)Earlier